These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 31456173

  • 1. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
    Vieira-Correa M, Giorgi RB, Oliveira KC, Hayashi LF, Costa-Barbosa FA, Kater CE.
    J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
    [Abstract] [Full Text] [Related]

  • 2. Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma.
    Ceccato F, Barbot M, Albiger N, Antonelli G, Zilio M, Todeschini M, Regazzo D, Plebani M, Lacognata C, Iacobone M, Mantero F, Boscaro M, Scaroni C.
    Endocrine; 2018 Mar; 59(3):510-519. PubMed ID: 28956262
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of salivary cortisol measurements for the diagnosis of subclinical Cushing's syndrome.
    Tateishi Y, Kouyama R, Mihara M, Doi M, Yoshimoto T, Hirata Y.
    Endocr J; 2012 Mar; 59(4):283-9. PubMed ID: 22261010
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test.
    Ueland GÅ, Methlie P, Kellmann R, Bjørgaas M, Åsvold BO, Thorstensen K, Kelp O, Thordarson HB, Mellgren G, Løvås K, Husebye ES.
    Eur J Endocrinol; 2017 Jun; 176(6):705-713. PubMed ID: 28298353
    [Abstract] [Full Text] [Related]

  • 5. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G, Allasino B, Bovio S, Saba L, Ardito A, Angeli A, Terzolo M.
    J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
    Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E, Mosconi C, Golfieri R, Paccapelo A, Pagotto U, Pasquali R.
    Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
    [Abstract] [Full Text] [Related]

  • 7. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M, Robles Lázaro C, Parra Ramírez P, Cuesta Hernández M, Sampedro Núñez MA, Marazuela M.
    Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
    [Abstract] [Full Text] [Related]

  • 8. Proposed diagnostic criteria for subclinical Cushing's syndrome associated with adrenal incidentaloma.
    Akehi Y, Kawate H, Murase K, Nagaishi R, Nomiyama T, Nomura M, Takayanagi R, Yanase T.
    Endocr J; 2013 Dec; 60(7):903-12. PubMed ID: 23574729
    [Abstract] [Full Text] [Related]

  • 9. Subclinical Cushing's syndrome in adrenal incidentaloma.
    Terzolo M, Osella G, Alì A, Borretta G, Cesario F, Paccotti P, Angeli A.
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
    [Abstract] [Full Text] [Related]

  • 10. Late-night and low-dose dexamethasone-suppressed cortisol in saliva and serum for the diagnosis of cortisol-secreting adrenal adenomas.
    Deutschbein T, Unger N, Hinrichs J, Walz MK, Mann K, Petersenn S.
    Eur J Endocrinol; 2009 Nov; 161(5):747-53. PubMed ID: 19726566
    [Abstract] [Full Text] [Related]

  • 11. Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
    Dennedy MC, Annamalai AK, Prankerd-Smith O, Freeman N, Vengopal K, Graggaber J, Koulouri O, Powlson AS, Shaw A, Halsall DJ, Gurnell M.
    J Clin Endocrinol Metab; 2017 Mar 01; 102(3):786-792. PubMed ID: 27797672
    [Abstract] [Full Text] [Related]

  • 12. Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency: improved screening by an automatic immunoassay.
    Deutschbein T, Broecker-Preuss M, Flitsch J, Jaeger A, Althoff R, Walz MK, Mann K, Petersenn S.
    Eur J Endocrinol; 2012 Apr 01; 166(4):613-8. PubMed ID: 22214924
    [Abstract] [Full Text] [Related]

  • 13. New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society.
    Yanase T, Oki Y, Katabami T, Otsuki M, Kageyama K, Tanaka T, Kawate H, Tanabe M, Doi M, Akehi Y, Ichijo T.
    Endocr J; 2018 Apr 26; 65(4):383-393. PubMed ID: 29576599
    [Abstract] [Full Text] [Related]

  • 14. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
    Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W.
    J Clin Endocrinol Metab; 1992 Sep 26; 75(3):826-32. PubMed ID: 1517373
    [Abstract] [Full Text] [Related]

  • 15. The association of cortisol and adrenal androgen with trabecular bone score in patients with adrenal incidentaloma with and without autonomous cortisol secretion.
    Kim BJ, Kwak MK, Ahn SH, Kim JS, Lee SH, Koh JM.
    Osteoporos Int; 2018 Oct 26; 29(10):2299-2307. PubMed ID: 29971455
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of the 1 mg overnight dexamethasone suppression test in the diagnosis of the subclinical Cushing's syndrome in patients with Adrenal Incidentaloma].
    Li L, Han B, Dou J, Yang G, Gu W, Lü Z, Mu Y.
    Zhonghua Yi Xue Za Zhi; 2015 Dec 19; 95(48):3912-6. PubMed ID: 27122212
    [Abstract] [Full Text] [Related]

  • 17. The Role of Cortisol/ACTH Ratio for Screening of Subclinical Hypercortisolism in Patients with Adrenal Incidentalomas.
    Li L, Yang G, Dou J, Gu W, Lv Z, Lu J, Mu Y.
    Exp Clin Endocrinol Diabetes; 2018 Feb 19; 126(2):71-76. PubMed ID: 28931176
    [Abstract] [Full Text] [Related]

  • 18. First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.
    Ceccato F, Antonelli G, Frigo AC, Regazzo D, Plebani M, Boscaro M, Scaroni C.
    J Endocrinol Invest; 2017 Jul 19; 40(7):753-760. PubMed ID: 28247215
    [Abstract] [Full Text] [Related]

  • 19. Visceral fat accumulation and postdexamethasone serum cortisol levels in patients with adrenal incidentaloma.
    Debono M, Prema A, Hughes TJ, Bull M, Ross RJ, Newell-Price J.
    J Clin Endocrinol Metab; 2013 Jun 19; 98(6):2383-91. PubMed ID: 23633207
    [Abstract] [Full Text] [Related]

  • 20. Cyclic Subclinical Hypercortisolism: A Previously Unidentified Hypersecretory Form of Adrenal Incidentalomas.
    Giorgi RB, Correa MV, Costa-Barbosa FA, Kater CE.
    J Endocr Soc; 2019 Mar 01; 3(3):678-686. PubMed ID: 30854503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.